{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T23:13:49Z","timestamp":1792970029627,"version":"4.5.0"},"reference-count":4,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:p>This cohort study examines the natural history and response to treatment of sodium glucose cotransporter 2 (SGLT2) inhibitor\u2013associated ketoacidosis compared with that of type 1 diabetes\u2013associated ketoacidosis.<\/jats:p>","DOI":"10.1001\/jamanetworkopen.2024.2744","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T11:35:04Z","timestamp":1710761704000},"page":"e242744","source":"Crossref","is-referenced-by-count":21,"title":["SGLT2 Inhibitor\u2013Associated Ketoacidosis vs Type 1 Diabetes\u2013Associated Ketoacidosis"],"prefix":"10.1001","volume":"7","author":[{"given":"Mahesh M.","family":"Umapathysivam","sequence":"first","affiliation":[{"name":"Southern Adelaide Diabetes and Endocrine Services, Flinders Medical Centre, Adelaide, South Australia, Australia"},{"name":"Endocrine Department, Queen Elizabeth Hospital, Woodville, South Australia, Australia"},{"name":"Endocrine Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia"},{"name":"Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia"},{"name":"Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Morgan","sequence":"additional","affiliation":[{"name":"Endocrine Department, Queen Elizabeth Hospital, Woodville, South Australia, Australia"},{"name":"Endocrine Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Inglis","sequence":"additional","affiliation":[{"name":"Endocrine Department, Queen Elizabeth Hospital, Woodville, South Australia, Australia"},{"name":"Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Meyer","sequence":"additional","affiliation":[{"name":"Endocrine Department, Queen Elizabeth Hospital, Woodville, South Australia, Australia"},{"name":"Endocrine Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia"},{"name":"Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Liew","sequence":"additional","affiliation":[{"name":"Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesan","family":"Thiruvenkatarajan","sequence":"additional","affiliation":[{"name":"Anaesthetic Department, Queen Elizabeth Hospital, Woodville, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jesudason","sequence":"additional","affiliation":[{"name":"Endocrine Department, Queen Elizabeth Hospital, Woodville, South Australia, Australia"},{"name":"Endocrine Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia"},{"name":"Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia"},{"name":"Basil Hetzel Institute Woodville, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"issue":"5","key":"zld240021r1","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.2337\/db15-1356","article-title":"Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes.","volume":"65","author":"Ferrannini","year":"2016","journal-title":"Diabetes"},{"issue":"10","key":"zld240021r2","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1056\/NEJMcibr1506573","article-title":"Type 2 diabetes, SGLT2 inhibitors, and glucose secretion.","volume":"373","author":"Hattersley","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"zld240021r3","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.2337\/dc21-1870","article-title":"Sodium-glucose cotransporter 2 inhibitor-linked pericolonoscopy hyperketonemia: a retrospective study.","volume":"45","author":"Thiruvenkatarajan","year":"2022","journal-title":"Diabetes Care"},{"issue":"6","key":"zld240021r4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.4158\/EP161292.PS","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis.","volume":"22","author":"Handelsman","year":"2016","journal-title":"Endocr Pract"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2816412\/umapathysivam_2024_ld_240021_1710514377.81441.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T11:35:07Z","timestamp":1710761707000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2816412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.2744","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]}}}